Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

More affordable pneumonia vaccine can protect more kids

Facts about pneumonia vaccine - January 2020
Facts about pneumonia vaccine - January 2020
Facts about pneumonia vaccine - January 2020
Facts about pneumonia vaccine - January 2020

Read, watch, share

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Anna Pantelia
Press release
Press release |
02 December 2019
Vaccines

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

5 min
MSF logistician, Athanasios Papadopoulos holding a sign advocating for broader use of the pneumonia vaccine at a lower price
Blog
Blog |
27 August 2019
Vaccines

The Inconvenient Truth About Pneumonia Vaccines

MSF logistician, Athanasios Papadopoulos holding a sign advocating for broader use of the pneumonia vaccine at a lower price Photograph by Anna Pantelia
Press release
Press release |
26 August 2019
Vaccines

Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine

5 min
•	MSF logistician, Athanasios Papadopoulos holding a sign advocating for broader use of the pneumonia vaccine at a lower price Anna Pantelia
Press release
Press release |
12 April 2019
Vaccines
EuropeGreece

Greece: MSF uses ‘Humanitarian Mechanism’ for first time in Europe due to high price of pneumonia vaccine

5 min
Registration area to define which vaccine children should receive. Photograph by Pierre-Yves Bernard
Feature story
Feature story |
19 July 2018
Vaccines
Central African Republic

The outcome of the two years mass vaccination campaign in Central African Republic

4 min
A nurse vaccinates a young Syrian girl against measles and pneumonia in Al-Atareb, Syria. MSF conducted a vaccination campaign targeting tens of thousands of children in partnership with the Syrian Immunization Group and Health Directorate of Aleppo, Syria. -Al-Atareb-14-4-2018 Roaa Hasan. Photograph by Roaa Hasan
Photo story
Photo story
|
07 May 2018
Vaccines
Syria

MSF helps vaccinate tens of thousands of displaced Syrian children

2 min
MSF Access Missions Lifesaving Treatment
Issue brief |
07 May 2018

Access Campaign Year in Review 2017

Vials of PCV13, a vaccine that protects children against pneumonia and meningitis. At 9 Euros a dose (three doses are necessary for the vaccine to be effective) PCV13 is currently priced at a rate much higher than most people in Central African Republic can afford. Photograph by Sandra Smiley Photograph by Sandra Smiley
Press release
Press release |
06 February 2018
Intellectual property and trade Vaccines
Republic of Korea

MSF challenges Pfizer’s monopoly on lifesaving pneumonia vaccine in Korea

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury